Robert H. Shoemaker
Impact in
- Toxicology top 0.05%
- Bioactive Compounds and Antitumor Agents
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 73
- Drug Transport and Resistance Mechanisms 15
- Cancer-related Molecular Pathways 12
- Cancer Cells and Metastasis 11
-
- Cancer, Hypoxia, and Metabolism 16
- Co-authors
- Dominic A. Scudiero (28 shared papers)Anne P. Monks (15 shared papers)Michael R. Boyd (27 shared papers)Kenneth D. Paull (5 shared papers)Donald L. Fine (5 shared papers)Betty J. Abbott (7 shared papers)Michael C. Alley (5 shared papers)Joseph G. Mayo (7 shared papers)
- Journals
- Journal of Natural Products (12 papers)JNCI Journal of the National Cancer Institute (10 papers)Cancer Research (9 papers)Journal of Medicinal Chemistry (9 papers)Cancer Prevention Research (6 papers)
- Partner nations
- United StatesGermanyMalaysia
In The Last Decade
Robert H. Shoemaker
186 papers receiving 20.6k citations
Robert H. Shoemaker's Hit Papers
Peers
Comparison fields: 5 of 173
- Toxicology 1.1k
- Cancer Research 2.8k
- Organic Chemistry 5.4k
- Virology 793
- Biotechnology 1.5k
Countries citing papers authored by Robert H. Shoemaker
This map shows the geographic impact of Robert H. Shoemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Shoemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Shoemaker more than expected).
Fields of papers citing papers by Robert H. Shoemaker
This network shows the impact of papers produced by Robert H. Shoemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Shoemaker. The network helps show where Robert H. Shoemaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert H. Shoemaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines Hit paper breakdown → | 1991 | 2969 |
| 2 | Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Hit paper breakdown → | 1988 | 2899 |
| 3 | The NCI60 human tumour cell line anticancer drug screen Hit paper breakdown → | 2006 | 2176 |
| 4 | Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Hit paper breakdown → | 1988 | 2152 |
| 5 | Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines Hit paper breakdown → | 1990 | 874 |
| 6 | Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm Hit paper breakdown → | 1989 | 859 |
| 7 | New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity Hit paper breakdown → | 1989 | 639 |
| 8 | 1997 | 525 | |
| 9 | 2005 | 459 | |
| 10 | Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. | 2002 | 412 |
| 11 | 2007 | 282 | |
| 12 | 2004 | 267 | |
| 13 | 1988 | 215 | |
| 14 | 2005 | 209 | |
| 15 | Application of a human tumor colony-forming assay to new drug screening. | 1985 | 196 |
| 16 | 1996 | 192 | |
| 17 | 2006 | 191 | |
| 18 | 2011 | 175 | |
| 19 | 2004 | 172 | |
| 20 | 2004 | 167 |
About Robert H. Shoemaker
Robert H. Shoemaker is a scholar working on Oncology, Cancer Research, Molecular Biology, Immunology and Biotechnology, having authored 191 papers that have together received 21.4k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (16 papers), Cancer therapeutics and mechanisms (16 papers), Immunotherapy and Immune Responses (15 papers), Drug Transport and Resistance Mechanisms (15 papers), Cancer-related Molecular Pathways (12 papers), RNA Interference and Gene Delivery (12 papers), Cancer Cells and Metastasis (11 papers) and Cancer Research and Treatments (10 papers). The work is most often cited by research in Toxicology (1.1k citations), Cancer Research (2.8k citations), Organic Chemistry (5.4k citations), Virology (793 citations) and Biotechnology (1.5k citations). Robert H. Shoemaker has collaborated with scholars based in United States, Germany and Malaysia. Frequent co-authors include Dominic A. Scudiero, Anne P. Monks, Michael R. Boyd, Kenneth D. Paull, Donald L. Fine, Betty J. Abbott, Michael C. Alley, Joseph G. Mayo, Philip Skehan and Giovanni Melillo. Their work appears in journals such as Journal of Natural Products, JNCI Journal of the National Cancer Institute, Cancer Research, Journal of Medicinal Chemistry and Cancer Prevention Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.